T8

· Shanghai Pharmaceuticals Holding Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T8, covering 2023-03-31 to 2023-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients [Phase 2]